Delivery Order SPE2DB25D3504-SPE2DB25FVVAB
Award Date 6/6/25
Potential Completion Date 6/9/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,012.76 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and narcolepsy. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order valued at $1,350.61 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The contract, established on September 8, 2025, with a completion date of September 9, 2025, was awarded under firm fixed pricing with no set-aside designation, indicating competitive selection. Performance will be executed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,896.20 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and narcolepsy. The contract, executed on August 13, 2025, with an ultimate completion date of August 14, 2025, operates under a firm fixed price structure with no set-aside designation, indicating competitive award to this qualified pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.38 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder. Issued on August 5, 2025, with an ultimate completion date of August 6, 2025, this firm fixed-price delivery order represents a single-transaction procurement under a competitive, non-set-aside arrangement. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,637.94 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription medication commonly used to treat attention-deficit/hyperactivity disorder. This contract, awarded on September 2, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,634.42 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,831.88 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 20 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The award, issued on July 8, 2025, with an ultimate completion date of July 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. This order was fulfilled from AmerisourceBergen's place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a $3,163.85 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. The contract, awarded on July 24, 2025, with completion targeted for July 25, 2025, carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from AmerisourceBergen's location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,958.84 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder. This non-competitive, firm fixed-price delivery order was issued on May 6, 2025, with an ultimate completion date of May 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,634.31 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, a prescription medication commonly used to treat attention-deficit/hyperactivity disorder. The contract, which was competitively awarded with no set-aside designation, carries a firm fixed price and was finalized on April 23, 2025, with an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is...